Moderna (XSWX:MRNA) Interest Expense: CHF-21 Mil (TTM As of Mar. 2026)


XSWX:MRNA Moderna Inc XSWX:MRNA
62 GF Score
Price CHF57.81
GF Value CHF18.28
! 7 Warning Signs
View Full Analysis

What is Moderna Interest Expense?

Moderna XSWX:MRNA 62 Interest Expense is CHF-21 Mil as of Mar. 2026. GuruFocus rates XSWX:MRNA with a GF Score™ of 62/100 and a GF Value™ of CHF18.28. The stock has 7 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Moderna's interest expense for the three months ended in Mar. 2026 was CHF -13 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF-21 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Moderna's Operating Income for the three months ended in Mar. 2026 was CHF -1,093 Mil. Moderna's Interest Expense for the three months ended in Mar. 2026 was CHF -13 Mil. Moderna did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Moderna  (XSWX:MRNA) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Moderna's Interest Expense for the three months ended in Mar. 2026 was CHF-13 Mil. Its Operating Income for the three months ended in Mar. 2026 was CHF-1,093 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was CHF983 Mil.

Moderna's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Moderna did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Moderna Interest Expense Historical Data

* Premium members only.

The historical data trend for Moderna's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna Interest Expense Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -16.58 -27.02 -32.86 -21.40 -7.97

Moderna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.88 -0.81 0.00 -6.38 -13.38
XSWX:MRNA
62GF Score
Moderna Inc XSWX:MRNA
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moderna Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF-21 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of CHF-21 Mil mean?
Moderna (XSWX:MRNA) has a Interest Expense of CHF-21 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Moderna and its competitors.
Is Moderna's Interest Expense too high?
Moderna's current Interest Expense is CHF-21 Mil. Overall, Moderna has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Moderna's Interest Expense compare to RPRX and ROIV?
Moderna's Interest Expense of CHF-21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Moderna and its competitors. Moderna's current Interest Expense is CHF-21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moderna stock overvalued right now?
Moderna (XSWX:MRNA) has a current Interest Expense of CHF-21 Mil. The stock's GF Value™ is CHF18.28, compared to a current price of CHF57.81 — trading 216.2% above its estimated fair value. The current Interest Expense is CHF-21 Mil. Moderna's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Moderna (XSWX:MRNA), the current Interest Expense is CHF-21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moderna (XSWX:MRNA) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of CHF57.81 is trading 216.2% above its estimated GF Value™ of CHF18.28.

Key valuation signals for XSWX:MRNA:

  • Interest Expense: CHF-21 Mil
  • GF Value™: CHF18.28 vs. price of CHF57.81 (216.2% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the XSWX:MRNA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
62GF Score

Get the complete analysis for XSWX:MRNA

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF57.81
Price
CHF18.28
GF Value